Prognosis of Cutaneous Lupus Erythematosus

  • Beate Tebbe
  • Constantin E. Orfanos


Systemic Lupus Erythematosus Human Leukocyte Antigen Cutaneous Lupus Erythematosus Congenital Heart Block Discoid Lupus Erythematosus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Asghar SS, Venneker GT, Van Meegen M, Meinardi MM, Hulsmans RF, de Waal LP (1991). Hereditary deficiency of C5 in association with discoid lupus erythematosus. J Am Acad Dermatol 24:376–378PubMedGoogle Scholar
  2. Bachmeyer C, Aractingi S, Blanc F, Verola O, Dubertret L (1992) Deep lupus erythematosus in children. Ann Dermatol Venereol 119:535–541PubMedGoogle Scholar
  3. Baker SB, Rovira JR, Campion EW, Mills JA (1979) Late onset systemic lupus erythematosus. Am J Med 66:727–732CrossRefPubMedGoogle Scholar
  4. Ballou SP, Khan MA, Jushner I (1982) Clinical features of systemic lupus erythematosus-differences related to race and age of onset. Arthritis Rheum 25:55–60PubMedGoogle Scholar
  5. Beutner EH, Blazczyk M, Jablonska S, Chorzelski TP, Kumar V, Wolska H (1991) Studies on criteria of the European Academy of Dermatology and Venerology for the classification of cutaneous lupus erythematosus. Int J Dermatol 30:411–417PubMedGoogle Scholar
  6. Bielsa I, Herrero C, Ercilla G, Collado A, Font J, Ingelmo M, Mascaro JM (1991) Immunogenetic findings in cutaneous lupus erythematosus. J Am Acad Dermatol 25:251–257PubMedGoogle Scholar
  7. Bleumink GS, ter Borg EJ, Ramselaar CG, Stricker BHCh (2001) Etanercept-induced subacute cutaneous lupus erythematosus. Rheumatology 40:1317–1319CrossRefPubMedGoogle Scholar
  8. Bonsmann G, Schiller M, Luger TA, Ständer S (2001) Terbinafine-induced subacute cutaneous lupus erythematosus. J Am Acad Dermatol 44: 925–931CrossRefPubMedGoogle Scholar
  9. Brucato A, Franceschini F, Buyon JP (1997) Neonatal lupus: long term outcomes of mothers and children and recurrence rate. Clin Exp Rheumatol 15:467–473PubMedGoogle Scholar
  10. Callen JP (1982) Chronic cutaneous lupus erythematosus. Clinical, laboratory, therapeutic and prognostic examination of 62 patients. Arch Dermatol 118:412–416CrossRefPubMedGoogle Scholar
  11. Callen JP (1985) Discoid lupus erythematosus: variants and clinical associations. Clin Dermatol 3:49–57CrossRefPubMedGoogle Scholar
  12. Callen JP, Kulick KB, Stelzer G, Fowler JF (1986) Subacutecut aneous lupus erythematosus. Clinical, serologic, and immunogenetic studies of 49 patients seen in a nonreferral setting. J Am Acad Dermatol 15:1227–1237PubMedGoogle Scholar
  13. Callen JP, Klein J (1988) Subacutecut aneous lupus erythematosus. Clinical serologic, immunogenetic, and therapeutic considerations in seventy-two patients. Arthritis Rheum 31: 1007–1013PubMedGoogle Scholar
  14. Callen JP (2001) Drug-induced cutaneous lupus erythematosus, a distinct syndrome that is frequently unrecognized. J Am Acad Dermatol 45: 315–316CrossRefPubMedGoogle Scholar
  15. Castanet J, Taillan B, Lacour JP, Garnier G, Perrin C, Ortonne JP (1995) Subacute cutaneous lupus erthymatosus associated with Hodgkin’s disease. Clin Rheumatol 14:692–694PubMedGoogle Scholar
  16. Chlebus E, Wolska H, Blaszczyk M, Jablonska S (1998) Subacute cutaneous lupus erythematosus versus systemic lupus erythematosus: diagnostic criteria and therapeutic implications. J Am Acad Dermatol 38:405–412PubMedGoogle Scholar
  17. Cohen MR, Crosby D (1994) Systemic disease in subacute cutaneous lupus erythematosus: a controlled comparison with systemic lupus erythematosus. J Rheumatol 21:1665–1669PubMedGoogle Scholar
  18. Crowson AN, Magro CM (1997) Subacute cutaneous lupus erythematosus arising in the setting of calcium channel blocker therapy. Hum Pathol 28:67–73CrossRefPubMedGoogle Scholar
  19. Dabski K, Stoll H, Milgrom H (1986) Squamous cell carcinoma complicating latechron ic discoid lupus erythematosus. J Surg Oncol 32:233–237PubMedGoogle Scholar
  20. Davidson BL, Gilliam JN, Lipsky PE (1982) Cimetidine-associated exacerbation of cutaneous lupus erythematosus. Arch Intern Med 142:166–167CrossRefPubMedGoogle Scholar
  21. Domenech I, Aydintug O, Cervera R, Khamashta M, Jedryka-Goral A (1992) Systemic lupus erythematosus in 50 years old. Postgrad Med J 68: 440–444PubMedGoogle Scholar
  22. Drenkard C, Alarcón-Segovia D (2000) The new prognosis of systemic lupus erythematosus:treatment-free remission and decreased mortality and morbidity. Irs Med Assoc J 2:382–387Google Scholar
  23. Egner W (2000) The use of laboratory tests in the diagnosis of SLE. J Clin Pathol 53:424–432CrossRefPubMedGoogle Scholar
  24. Fanti PA, Tosti A, Peluso AM, Bonelli U (1989) Multiple keratoacanthoma in discoid lupus erythematosus. J Am Acad Dermatol 21:809–810Google Scholar
  25. Fernandez-Diaz ML, Herranz P, Suarez-Marrero MC, Vorbujo J, Manzano R, Casado M (1995) Subacute lupus erythematosus associated with cilazapril. Lancet 345:398CrossRefGoogle Scholar
  26. Fonseca E, Alvarez R, Gonzalez MR, Pascual D (1992) Prevalence of anticardiolipin antibodies in subacute cutaneous lupus erythematosus. Lupus 1:265–268PubMedGoogle Scholar
  27. Font J, Pallares L, Cervera R, Lopez-Soto A, Navarro M, Bosch X, Ingelmo M (1991) Systemic lupus erythematosus in the elderly: clinical and immunological characteristics. Ann Rheum Dis 50:702–705PubMedGoogle Scholar
  28. Font J, Cervera R, Navarro M, Pallares L, Lopez-Soto A, Vivancos J, Ingelmo M (1992) Systemic lupus erythematosus in men: clinical and immunological characteristics. Ann Rheum Dis 51:1050–1052PubMedGoogle Scholar
  29. Font J, Cervera R, Espinosa G, Pallares L, Ramos-Casals M, Jimenez S, Garcia-Carrasco M, Seis-dedos L, Ingelmo M (1998) Systemic lupus erythematosus (SLE) in childhood: analysis of clinical and immunological findings in 34 patients and comparison with SLE characteristics in adults. Ann Rheum Dis 57:456–459PubMedGoogle Scholar
  30. Formiga F, Moga I, Pac M, Mitjavila F, Rivera A, Pujol R (1999) Mild presentation of systemic lupus erythematosus in elderly patients assessed by SLEDAI. Lupus 8:462–465PubMedGoogle Scholar
  31. Fowler JF, Callen JP, Stelzer GT, Cotter PK (1985) Human histocompatibility antigen associations in patients with chronic cutaneous lupus erythematosus. J Am Acad Dermatol 12:73–77PubMedGoogle Scholar
  32. Furukawa F, Tachibana T, Imamura S, Tamura T (1991) Oral contraceptives induced lupus erythematosus in a Japanese woman. J Dermatol 18: 56–58PubMedGoogle Scholar
  33. George PM, Tunnessen WW Jr (19 93) Childhood discoid lupus erythematosus. Arch Dermatol 129:613–617CrossRefGoogle Scholar
  34. Gladman DD (1996) Prognosis and treatment of systemic lupus erythematosus. Curr Opin Rheum 8:430–437Google Scholar
  35. Halder RM, Bridgeman-Shah S (1995) Skin cancer in African Americans. Cancer 75:667–673PubMedGoogle Scholar
  36. Hasan T, Nyberg F, Stephansson E, Puska P, Häkkinen M, Sarna S, Ros AM, Ranki A (1997) Photosensitivity in lupus erythematosus, UV photoprovocation results compared with history of photosensitivity and clinical findings. Br J Dermatol 136:699–705CrossRefPubMedGoogle Scholar
  37. Healy E, Kieran E, Rogers S (1995) Cutaneous lupus erythematosus — astudy of clinical and laboratory prognostic factors in 65 patients. Israel J Med Sci 164:113–113Google Scholar
  38. Herrero C, Bielsa I, Font J, Lozano F, Ericilla G, Lecha M, Ingelmo M, Mascaro JM (1988) Subacute cutaneous lupus erythematosus: clinical pathologic findings in 13 cases. J Am Acad Dermatol 19:1057–1062PubMedGoogle Scholar
  39. Higuchi T, Imamura S, Danno K (1978) Prognosis of discoid lupus erythematosus. Acta Derm 73:197–204Google Scholar
  40. Ho CC, Mok CC, Lau CS, Wong RWS (1998) Late onset systemic lupus erythematosus in southern Chinese. Ann Rheum Dis 57:437–440PubMedGoogle Scholar
  41. Ho C, Shumack SP, Morris D (2001) Subacute cutaneous lupus erythematosus associated with hepatocellular carcinoma. Austral J Dermatol 42:110–113CrossRefGoogle Scholar
  42. Hochberg MC (1997) The epidemiology of systemic lupus erythematosus. In: Wallace DJ, Hahn BH (eds) Dubois’ lupus erythematosus. Lea & Febiger, Philadelphia, pp 49–65Google Scholar
  43. Howard PF, Hochberg MC, Bias WB, Arnett FC, McLean RH (1986) Relationship between C4 null genes, HLA D regionantigens, and genetic susceptibility to lupus erythematosus in Caucasians and black Americans. Am J Med 81:187–193CrossRefPubMedGoogle Scholar
  44. Johansson-Stephansson E, Koskimies S, Partanen J, Kariniemi AL (1989) Subacutecut aneous lupus erythematosus. Genetic markers and clinical and immunological findings in patients. Arch Dermatol 125:791–796CrossRefPubMedGoogle Scholar
  45. Kammer GM, Mishra N (2000) Systemic lupus erythematosus in the elderly. Rheum Dis Clin North Am 26:475–492PubMedGoogle Scholar
  46. Kanda N, Tsuchida T, Watanabe T, Tamaki K (1996) Clinical features of systemic lupus erythematosus in men. Dermatology 193:6–10PubMedGoogle Scholar
  47. Kaufman LD, Gomez-Reino JJ, Mark H, Heinicke MH, Gorevic PD (1989) Male lupus: retrospective analysis of the clinical and laboratory features of 52 patients, with a review of the literature. Semin Arthritis Rheum 18:189–197CrossRefPubMedGoogle Scholar
  48. Kind P, Goerz G (1987) Klinische Aspekte und Differentialdiagnose des kutanen Lupus erythematodes. Z Hautkr 62:1337–1347PubMedGoogle Scholar
  49. Kind P, Schuppe HC, Jung KP, Degitz K, Lakomek HJ, Goerz G (1992) Kutaner Lupus erythematodes und Kardiolipin-Antikörper. Vorkommen und klinische Bedeutung. Hautarzt 43:126–129PubMedGoogle Scholar
  50. Knop J, Bonsmann G, Kind P, Doxiadis I, Vogeler U, Goerz G, Grosse-Wilde H (1990) Antigens of the major histocompatibility complex in patients with chronic discoid lupus erythematosus. Br J Dermatol 122:723–728PubMedGoogle Scholar
  51. Koh ET, Boey ML (1994) Late onset lupus: a clinical and immunological study in a predominantly Chinese population. J Rheumatol 21:1463–1467PubMedGoogle Scholar
  52. Koh WH, Fong KY, Boey ML, Feng PH (1994) Systemic lupus erythematosus in 61 oriental males. A study of clinical and laboratory manifestations. Br J Rheumatol 33:339–342PubMedGoogle Scholar
  53. Kuhn A, Kaufmann I (1986) Subakut kutaner Lupus erythematodes als paraneoplastisches Syndrom. Z Hautkr 61:581–583PubMedGoogle Scholar
  54. Kuhn A, Richter-Hintz D, Oslislo C, Ruzicka T, Megahed M, Lehmann P (2000) Lupus erythematosus tumidus — a neglected subset of cutaneous lupus erythematosus: report of 40 cases. Arch Dermatol 136:1033–1041PubMedGoogle Scholar
  55. Kuhn A, Sonntag M, Richter-Hintz D, Oslislo C, Megahed M, Ruzicka T, Lehmann P (2001) Phototesting in lupus erythematosus: a 15-year experience. J Am Acad Dermatol 45:86–95CrossRefPubMedGoogle Scholar
  56. LeBozec P, La Guyadec T, Crickx B, Grossin M, Belaich S (1994) Chronic lupus erythematosus in lupus disease. Retrospective study in 136 cases. Presse Med 23:1598–1602PubMedGoogle Scholar
  57. Lee LA, Weston WL (1997) Cutaneous lupus erythematosus during the neonatal and childhood periods. Lupus 6:132–138PubMedGoogle Scholar
  58. Lehman TJ (1995) A practical guide to systemic lupus erythematosus. Pediatr Clin North Am 42:1223–1238PubMedGoogle Scholar
  59. Lehmann P, Holzle E, Kind P, Goerz, Plewig G (1990) Experimental reproduction of skin lesions in lupus erythematosus by UVA and UVB radiation. J Am Acad Dermatol 22:181–187PubMedGoogle Scholar
  60. Lipsker DM, Schreckenberg-Gilliot C, Uring-Lambert B, Meyer A, Hartmann D, Grosshans EM, Hauptmann G (2000) Lupus erythematosus associated with genetically determined deficiency of the second component of the complement. Arch Dermatol 136:1508–1514CrossRefPubMedGoogle Scholar
  61. Lo JT, Tsai MJ, Wang LH, Huang MT, Yang YH, Lin YT, Liu J, Chiang BL (1999) Sex differences in pediatric systemic lupus erythematosus: a retrospective analysis of 135 cases. J Microbiol Immunol Infect 32:173–178PubMedGoogle Scholar
  62. López-Longo FJ, Monteagudo I, González CM, Grau R, Carreno L (1997) Systemic lupus erythematosus: clinical expression and anti-Ro/SS-A response in patients with and without lesions of subacutecut aneous lupus erythematosus. Lupus 6:32–39PubMedGoogle Scholar
  63. Maddison PJ (1987) Systemic lupus erythematosus in the elderly. J Rheumatol 14(Suppl 13): 182–187PubMedGoogle Scholar
  64. Mak SK, Lam EKM, Wong AKM (1998) Clinical profile of patients with late-onset SLE: not a benign subgroup. Lupus 7:23–28CrossRefPubMedGoogle Scholar
  65. Martens PB, Moder KG, Ahmed I (1999) Lupus panniculitis: clinical perspectives from a case series. J Rheumatol 26:68–72PubMedGoogle Scholar
  66. McCauliffe DP, Faircloth E, Wang L, Hashimoto T, Hoshino Y, Nishikawa T (1996) Similar Ro/SS-A autoantibody epitope and titer responses in annular erythema of Sjogren’s syndrome and subacute cutaneous lupus erythematosus. Arch Dermatol 132:528–531CrossRefPubMedGoogle Scholar
  67. Meier CR, Sturkenboom MCJM, Cohen AS, Jick H (1998) Postmenopausal estrogen replacement therapy and the risk of developing systemic lupus erythematosus or discoid lupus. J Rheumatol 25:1515–1519PubMedGoogle Scholar
  68. Meyer O, Hauptmann G, Tappeiner G, Ochs HD, Mascart-Lemone F (1985) Genetic deficiency of C4, C2 or C1q and lupus syndromes. Association with anti-Ro (SS-A) antibodies. Clin Exp Immunol 62:678–684PubMedGoogle Scholar
  69. Millard LG, Rowell NR, Rajah SM (1977) Histocompatibility antigens in discoid and systemic lupus erythematosus. Br J Dermatol 96:139–144PubMedGoogle Scholar
  70. Millard LG, Barker DJ (1978) Development of squamous cell carcinoma in chronic discoid lupus erythematosus. Clin Exp Dermatol 3:161–166PubMedGoogle Scholar
  71. Millard LG, Rowell NR (1979) Abnormal laboratory test results and their relationship to prognosis in discoid lupus erythematosus: a longterm follow-upstudy of 92 patients. Arch Dermatol 115:1055–1058CrossRefPubMedGoogle Scholar
  72. Millard TP, Kondeatis E, Vaughan RW, Lewis CM, Khamashta MA, Hughes GR, Hawk JL, McGregor JM (2001) Polymorphic light eruption and the HLA DRB1*0301 extended haplotype are independent risk factors for cutaneous lupus erythematosus. Lupus 10:473–479CrossRefPubMedGoogle Scholar
  73. Millard TP, Lewis CM, Khamashta MA, Hughes GRV, Hawk JLM, McGregor JM (2001) Familial clustering of polymorphic light eruption in relatives of patients with lupus erythematosus: evidence of a shared pathogenesis. Br J Dermatol 144:334–338CrossRefPubMedGoogle Scholar
  74. Miller MH, Urowitz MB, Gladman DD, Killinger DW (1983) Systemic lupus erythematosus in males. Medicine 62:327–334PubMedGoogle Scholar
  75. Miyagawa S, Okuchi T, Shiomi Y, Sakamoto K (1989) Subacute cutaneous lupus erythematosus lesions precipitated by griseofulvin. J Am Acad Dermatol 21:343–346PubMedGoogle Scholar
  76. Miyagawa S. Clinical, serological and immunogenetic features of Japanese anti-Ro/SS-A-positive patients with annular erythema. Dermatology 189(Suppl 1):11–13Google Scholar
  77. Molad Y (1987) Clinical manifestations and laboratory data of subacute cutaneous lupus erythematosus. Israel J Med Sci 23:278–280PubMedGoogle Scholar
  78. Mooney E, Wade TR (1989) Subacute cutaneous lupus erythematosus in Iceland. Int J Dermatol 28:104–106PubMedGoogle Scholar
  79. Moschella SL (1989) Dermatologic overview of lupus erythematosus and its subsets. J Dermatol 16:417–428PubMedGoogle Scholar
  80. Murphy GM, Hawk JL (1991) The prevalence of antinuclear antibodies in patients with apparent polymorphic light eruption. Br J Dermatol 125:448–451PubMedGoogle Scholar
  81. Neiman AR, Lee LA, Weston WL, Buyon JP (2000) Cutaneous manifestations of neonatal lupus without heart block: characteristics of mothers and children enrolled in a national registry. J Pediatr 137:674–680CrossRefPubMedGoogle Scholar
  82. Nousari HC, Kimyai-Asadi A, Tausk FA (1998) Subacute cutaneous lupus erythematosus associated with interferon beta-1α. Lancet 352: 1825–1826Google Scholar
  83. Nyberg F, Hasan T, Puska P, Stephansson E, Hakkinen M, Ranki A, Ros AM (1997) Occurrence of polymorphous light eruption in lupus erythematosus. Br J Dermatol 136:217–221CrossRefPubMedGoogle Scholar
  84. O’Loughlin S, Schroeter AL, Jordan RE (1978) A study of lupus erythematosus with particular reference to generalized discoid lupus. Br J Dermatol 99:1–11PubMedGoogle Scholar
  85. Parodi A, Rebora A (1997) ARA and EADV criteria for classification of systemic lupus erythematosus in patients with cutaneous lupus erythematosus. Dermatology 194:217–220PubMedGoogle Scholar
  86. Parodi A, Caproni M, Cardinali C, Bernacchi E, Fuligni A, De Panfilis G, Zane C, Papini M, Veller FC, Vaccaro M, Fabbri P (2000) Clinical, histological and immunopathological features of 58 patients with subacute cutaneous lupus erythematosus. Dermatology 200:6–10PubMedGoogle Scholar
  87. Parodi A, Massone C, Cacciapuoti M, Aragone MG, Bondavalli P, Cattarini G, Rebora A (2000) Measuring the activity of the disease in patients with cutaneous lupus erythematosus. Br J Dermatol 142:457–460CrossRefPubMedGoogle Scholar
  88. Partanen J, Koskimies S, Johansson E (1988) C4 null phenotypes among lupus erythematosus patients are predominantly the result of deletions covering C4 and closely linked C21-hydroxylase A genes. J Med Genet 25:387–391PubMedGoogle Scholar
  89. Perkins W, Stables GI, Lever RS (1994) Protein S deficiency in lupus erythematosus secondary to hereditary angio-oedema. Br J Dermatol 130:381–384PubMedGoogle Scholar
  90. Petri M, McLean RH, Watson R, Winckelstein JA (1993) Clinical expression of systemic lupus erythematosus in patients with C4A deficiency. Medicine 72:236–244PubMedGoogle Scholar
  91. Provost TT, Arnett FC, Reichlin M (1983) Homozygous C2 deficiency, lupus erythematosus and anti-Ro (SSA) antibodies. Arthritis Rheum 26:1279–1283PubMedGoogle Scholar
  92. Provost TT, Talal N, Bias W, Harley JB, Reichlin M, Alexander EL (1988) Ro/SS-A (SS-A) positive Sjogren’s/lupus erythematosus overlap patients are associated with the HLA-DR3 and/or DRW6 phenotypes. J Invest Dermatol 91:369–371PubMedGoogle Scholar
  93. Provost TT, Watson R, Simmons-O’Brien E (1996) Significance of the anti-Ro(SS-A) antibody in evaluation of patients with cutaneous manifestations of a connective tissue disease. J Am Acad Dermatol 35:147–169CrossRefPubMedGoogle Scholar
  94. Pu SJ, Luo SF, Wu YJJ, Cheng HS, Ho HH (2000) The clinical features and prognosis of lupus with disease onset at age 65 and older. Lupus 9: 96–100PubMedGoogle Scholar
  95. Ratnoff WD (1996) Inherited C2 deficiency of complement in rheumatic diseases. Rheum Dis Clin North Am 22:75–94PubMedGoogle Scholar
  96. Reed BR, Huff JC, Jones SK, Orton PW, Lee LA, Norris DA (1985) Subacute cutaneous lupus erythematosus associated with hydrochlorothiazide therapy. Ann Intern Med 103:49–51PubMedGoogle Scholar
  97. Richardson TT, Cohen PR (2000) Subacute cutaneous lupus erythematosus: report of apatient who subsequently developed a meningioma and whose skin lesions were treated with isotretinoin. Cutis 66:183–188PubMedGoogle Scholar
  98. Rood MJ, ten Cate R, ven Suijlekom-Smit LW, den Ouden EJ, Ouwerkerk FE, Breedveld FC, Huizinga TW (1999) Childhood-onset systemic lupus erythematosus: clinical presentation and prognosis in 31 patients. Scand J Rheumatol 28:222–226PubMedGoogle Scholar
  99. Rowell NR (1984) The natural history of lupus erythematosus. Clin Exp Dermatol 9:217–231PubMedGoogle Scholar
  100. Schaller J (1982) Lupus in childhood. Clin Rheum Dis 8:219–228PubMedGoogle Scholar
  101. Schiodt M (1984) Oral discoid lupus erythematosus. 2. Skin lesions and systemic lupus erythematosus in sixty-six patients with 6-year follow up. Oral Surg 57:177–180PubMedGoogle Scholar
  102. Schur PH (1978) Genetics of complementde ficiencies associated with lupus-like syndromes. Arthritis Rheum 21(Suppl 5):S153–S160PubMedGoogle Scholar
  103. Sequeira JF, Keser G, Greenstein B, Wheeler MJ, Duarte PC, Khamashta MA, Hughes GR (1993) Systemic lupus erythematosus: Sex hormones in male patients. Lupus 2:315–317PubMedGoogle Scholar
  104. Shai R, Quismorio FP Jr, Li L, Kwon OJ, Morrison J, Wallace DJ, Neuwelt CM, Brautbar C, Gauderman WJ, Jacob CO (1999) Genome-wide screen for systemic lupus erythematosus susceptibility gene in multiplex families. Hum Mol Genet 8:639–644PubMedGoogle Scholar
  105. Shaikh SK, Wang F (1995) Late-onset systemic lupus erythematosus: clinical and immunological characteristics. Med J Malaysia 50:25–31PubMedGoogle Scholar
  106. Simmons-O’Brien E, Chen S, Watson R, Antoni C, Petri M, Hochberg M, Stevens MB, Provost TT (1995) One hundred anti-Ro (SS-A) antibody positive patients: a 10-year follow-up. Medicine (Baltimore) 74:109–130CrossRefGoogle Scholar
  107. Sontheimer RD, Thomas JR, Gilliam JN (1979) Subacute cutaneous lupus erythematosus: a cutaneous marker for a distinct lupus erythematosus subset. Arch Dermatol 115:1409–1415CrossRefPubMedGoogle Scholar
  108. Sontheimer RD, Stastny P, Gilliam JN (1981) Human histocompatibility antigen associations in subacute cutaneous lupus erythematosus. J Clin Invest 67:312–316PubMedGoogle Scholar
  109. Sontheimer RD (1989) Subacute cutaneous lupus erythematosus: a decade’s perspective. Med Clin North Am 73:1073–1090PubMedGoogle Scholar
  110. Stavropoulos PG, Tebbe B, Tenorio S, Orfanos CE (1996) LE-associated squamous cell carcinoma. Eur J Dermatol 6:48–50Google Scholar
  111. Stephens HA, McHugh NJ, Maddison PJ, Isenberg DA, Welsh KI, Panayi GS (1991) HLA class II restriction of autoantibody production in patients with systemic lupus erythematosus Immunogenetics 33:276–280Google Scholar
  112. Sullivan KE (1998) Complement deficiency and autoimmunity. Curr Opin Pediatr 10:600–606PubMedGoogle Scholar
  113. Swaak AJG (1989) Systemic lupus erythematosus. I. Outcome and survival: Dutch experience with 110 patients studied prospectively. Ann Rheum Dis 48:447–454PubMedGoogle Scholar
  114. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25: 1271–1277PubMedGoogle Scholar
  115. Tebbe B, Orfanos CE (1987) Lupus erythematodes der Haut. Eine Analyse von 97 Patienten. Z Hautkr 62:1563–1584PubMedGoogle Scholar
  116. Tebbe B, Orfanos CE (1992) Anticardiolipin-Antikörper beim kutanen Lupus erythematodes. Hautarzt 43:130–133PubMedGoogle Scholar
  117. Tebbe B, Hoffmann S, Orfanos CE (1994) Verlauf und Prognose des subakut kutanen Lupus erythematodes. Hautarzt 45:690–695PubMedGoogle Scholar
  118. Tebbe B, Mansmann U, Wollina U, Auer-Grumbach P, Licht-Mbalyohere A, Arensmeier M, Orfanos CE (1997) Markers in cutaneous lupus erythematosus indicating systemic involvement. Amulticenter study on 296 patients. Acta Derm Venereol 77:305–308PubMedGoogle Scholar
  119. Toll A, Campo-Pisa P, Gonzalez-Castro J, Campo-Voegeli A, Azon A, Iranzo P, Lecha M, Herrero C (1998) Subacute cutaneous lupus erythematosus associated with cinnarizine and thiethylperazine therapy. Lupus 7364–366Google Scholar
  120. Tongio MM, Fersing J, Hauptmann G, Mayer S, Grange D, Samsoen M, Groshans E (1982) HLA antigens in discoid lupus erythematosus. Acta Derm Venereol 62:155–157PubMedGoogle Scholar
  121. Trueb RF, Trueb RM (1999) Kutane Paraneoplasie als immunologisches Phänomen am Beispiel des paraneoplastischen subakut kutanen Lupus erythematodes. Schweiz Rundsch Med Prax 88:1803–1810PubMedGoogle Scholar
  122. van Weelden H, Velthuis PJ, Baart de la Faille H (1989) Light-induced skin lesions in lupus erythematosus: photobiological studies. Arch Dermatol Res 28:1470–474Google Scholar
  123. Wallace DJ, Pistiner M, Nessim S, Metzger AL, Klinenberg JR (1992) Cutaneous lupus erythematosus without systemic lupus erythematosus. Clinical and laboratory features. Semin Arthritis Rheum 21:221–226CrossRefPubMedGoogle Scholar
  124. Wananukul S, Watana D, Pongprasit P (1998) Cutaneous manifestations of childhood systemic lupus erythematosus. Pediatr Dermatol 15:342–346CrossRefPubMedGoogle Scholar
  125. Ward MM, Polisson RP (1989) A meta-analysis of the clinical manifestations of older-onset systemic lupus erythematosus. Arthritis Rheum 32:1226–1232PubMedGoogle Scholar
  126. Watanabe T, Tsuchida T (1995) Classification of lupus erythematosus based upon cutaneous manifestations. Dermatology 190:277–283PubMedGoogle Scholar
  127. Watanabe T, Tsuchida T (1996) Lupus erythematosus profundus: a cutaneous marker for a distinct clinical subset? Br J Dermatol 134:123–125CrossRefPubMedGoogle Scholar
  128. Watanabe T, Tsuchida T, Ito Y, Kanda N, Ueda Y, Tamaki K (1997) Annular erythema associated with lupus erythematosus/Sjogren’s syndrome. J Am Acad Dermatol 36:214–218PubMedGoogle Scholar
  129. Watson RM, Talwar P, Alexander E, Bias WB, Provost TT (1991) Subacutecut aneous lupus erythematosus-immunogenetic associations. J Autoimmun 4:73–85CrossRefPubMedGoogle Scholar
  130. Werth VP, Zhang W, Dortzbach K, Sullivan K (2000) Association of a promoter polymorphism of tumour necrosis factor-alpha (TNF-alpha) with subacutecut aneous lupus erythematosus. J Invest Dermatol 115:726–730CrossRefPubMedGoogle Scholar
  131. Wilson AG, de Vries N, Pociot F, diGiovine FS, van der Putte LB, Duff GW (1993) An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J Exp Med 177:557–560Google Scholar
  132. Yell JA, Burge SM (1993) The effect of hormonal changes on cutaneous disease in lupus erythematosus. Br J Dermatol 129:18–22PubMedGoogle Scholar
  133. Zecevic RD, Vojvodvic D, Ristic B, Pavlovic MD, Stefanovic D, Karadaglic D (2001) Skin lesions — an indicator of disease activity in systemic lupus erythematosus? Lupus 10:364–367CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 2005

Authors and Affiliations

  • Beate Tebbe
  • Constantin E. Orfanos

There are no affiliations available

Personalised recommendations